Stocks
Intra-Cellular Therapies (ITCI) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.98 | -79.0 | 2.17 | 3.03 | -65.4 | -108.6 | ||
| Changes by years, y/y, % | -37% | +1 033% | -103% | +39% | -2 259% | +42.8% | |||
Intra-Cellular Therapies. EV/EBITDA
Intra-Cellular Therapies. EV/EBITDA, changes, %
Intra-Cellular Therapies (ITCI) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| EV/EBITDA | ? | 3.03 | 3.51 | 8.99 | -55.7 | -65.7 | -108.6 | |
| Changes by years, y/y, % | +39% | -118% | -132% | -2 118% | -2 268% | |||
| Changes by quarters, q/q, % | +10% | +16% | +156% | -720% | +18% | |||
